Medical Device Cleanliness: When and How to adjust LIMIT VALUES for Residual Analysis

This product is currently out of stock and unavailable.

Description:

This webinar will provide valuable guidance to medical device manufacturers on how to establish and justify limit values for cleanliness. There are several techniques that may be used to set these limits, including comparison involving statistics and historical data. Justification techniques include biocompatibility and risk assessment. Regardless of what technique is used, regulatory agencies expect that limit values will be set for residual analysis.

The FDA and other regulatory agency do not intend to set acceptance specifications or methods for determining whether a cleaning process in validated. They expect medical device manufacturers to establish and justify cleanliness specification for their devices. Although some documents are in the pipeline, there is no approved standard that provides guidance on how to set and justify limit values for residual analysis.

Areas to be Covered:

Expectations of regulatory agencies on cleanliness specifications
How to Express Residue Limit Values
Statistical Comparison
Baseline Comparison
Biocompatibility
Risk-based Assessment
When and how to adjust limit values

Who will Benefit:

QA/QC managers and personnel
Validation managers and personnel
Operations and Manufacturing
R&D and Engineering
R&D management
Engineering management
Production management
Production engineers

Kierstan Andrascik

Kierstan Andrascik, founder of QVET Consulting, with her years of experience in the medical device industry assists manufacturers with their validation needs. She specializes in cleaning validations for both new and reprocessed medical devices and has established herself as one of the foremost experts in medical device cleanliness. She also provides guidance in many other areas including sterilization, biocompatibility, packaging, and materials characterization. Previously, she worked at Nelson Laboratories in Salt Lake City, Utah where she served as study director covering a variety of testing including new device cleaning validations, materials characterization, and package testing.

In 2002, she began developing a method to quantify residual manufacturing materials on medical devices. In 2005, ASTM published a similar method as F2459. Kierstan has been actively serving on the ASTM Device Cleanliness subcommittee since 2005. She received a Certificate of Achievement from ASTM in May 2007. In the June 2008 issue of Medical Design magazine, her article titled “How to tell if a device is really clean” was published. Then, in April 2011, her chapter “Cleaning Validations using Extraction Techniques” published in the 2nd edition of Handbook for Critical Cleaning. She has a BS in chemistry and mathematics, and an AS in Engineering from Shepherd University in Shepherdstown, West Virginia.

This product is currently out of stock and unavailable.

membership
  Go PRIME   🛈 $ 240 SELECT
  Personal Plan 🛈 $ 3000 SELECT
  Business Plan 🛈 $ 9000 SELECT


  • Login Information with Password to join the session, 24 hours prior to the webinar
  • Presentation Handout in .pdf format
  • Presentation from the Speaker
  • Feedback form
  • Certificate of Attendance
  • Recording access Information with Password to view the webinar, will be sent 24 hours after the completion of the Live webinar.
  • Presentation Handout in .pdf format
  • Certificate of Attendance